John Perrett
Impact in
-
- Cystic Fibrosis Research Advances
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neonatal Respiratory Health Research
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Neonatal Respiratory Health Research 2
- Respiratory and Cough-Related Research 2
- Respiratory Support and Mechanisms 2
-
- Antiplatelet Therapy and Cardiovascular Diseases 1
- Co-authors
- Kulasiri A. Gunawardena (5 shared papers)Neil Entwistle (2 shared papers)Kristina Forsman‐Semb (2 shared papers)Robert Andrew Stockley (1 shared paper)Noel J C Snell (1 shared paper)Anthony De Soyza (1 shared paper)Claus Franz Vogelmeier (2 shared papers)Christopher David O'Brien (2 shared papers)
- Journals
- Respiratory Medicine (2 papers)COPD Journal of Chronic Obstructive Pulmonary Disease (2 papers)British Journal of Clinical Pharmacology (1 paper)European Respiratory Journal (1 paper)Blood (1 paper)
- Partner nations
- United KingdomSwedenGermany
In The Last Decade
John Perrett
9 papers receiving 443 citations
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 229
- Pharmacology 53
- Immunology 114
- Cancer Research 55
- Immunology and Allergy 15
Countries citing papers authored by John Perrett
This map shows the geographic impact of John Perrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Perrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Perrett more than expected).
Fields of papers citing papers by John Perrett
This network shows the impact of papers produced by John Perrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Perrett. The network helps show where John Perrett may publish in the future.
Co-authors
The 22 scholars most cited alongside John Perrett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 171 | |
| 2 | 2012 | 82 | |
| 3 | 2012 | 70 | |
| 4 | 2003 | 60 | |
| 5 | 2003 | 21 | |
| 6 | The role of the novel D2/beta2-agonist, Viozan (sibenadet HCl), in the treatment of symptoms of chronic obstructive pulmonary disease: results of a large-scale clinical investigation. | 2003 | 20 |
| 7 | 2013 | 18 | |
| 8 | The P-2t antagonist AR-C69931MX is a more effective inhibitor of ADP-induced platelet aggregation than clopidogrel. | 1999 | 12 |
| 9 | 2012 | 2 |
About John Perrett
John Perrett is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Pharmacology, Pharmacology and Physiology, having authored 9 papers that have together received 456 indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Neonatal Respiratory Health Research (2 papers), Respiratory and Cough-Related Research (2 papers), Respiratory Support and Mechanisms (2 papers), Pharmacology and Obesity Treatment (1 paper), Neonatal and Maternal Infections (1 paper), Lipoproteins and Cardiovascular Health (1 paper) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (229 citations), Pharmacology (53 citations), Immunology (114 citations), Cancer Research (55 citations) and Immunology and Allergy (15 citations). John Perrett has collaborated with scholars based in United Kingdom, Sweden and Germany. Frequent co-authors include Kulasiri A. Gunawardena, Neil Entwistle, Kristina Forsman‐Semb, Robert Andrew Stockley, Noel J C Snell, Anthony De Soyza, Claus Franz Vogelmeier, Christopher David O'Brien, J. Stuart Elborn and Joanna Marks-Kończalik. Their work appears in journals such as Respiratory Medicine, COPD Journal of Chronic Obstructive Pulmonary Disease, British Journal of Clinical Pharmacology, European Respiratory Journal and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.